Glucose and glycogen in the diabetic kidney: Heroes or villains?

[1]  J. Egido,et al.  Lipotoxicity and Diabetic Nephropathy: Novel Mechanistic Insights and Therapeutic Opportunities , 2020, International journal of molecular sciences.

[2]  Aftab Ahmad,et al.  Catharanthus roseus Combined with Ursolic Acid Attenuates Streptozotocin-Induced Diabetes through Insulin Secretion and Glycogen Storage , 2020, Oxidative medicine and cellular longevity.

[3]  Jun Gu,et al.  Klotho inhibits PKCα/p66SHC-mediated podocyte injury in diabetic nephropathy , 2019, Molecular and Cellular Endocrinology.

[4]  F. Nitschke,et al.  Skeletal Muscle Glycogen Chain Length Correlates with Insolubility in Mouse Models of Polyglucosan-Associated Neurodegenerative Diseases. , 2019, Cell reports.

[5]  B. Schulz,et al.  Proteomic Investigation of the Binding Agent between Liver Glycogen β Particles , 2018, ACS omega.

[6]  Cheng Li,et al.  Diurnal changes of glycogen molecular structure in healthy and diabetic mice. , 2018, Carbohydrate polymers.

[7]  J. Forbes,et al.  Mitochondrial dysfunction in diabetic kidney disease , 2018, Nature Reviews Nephrology.

[8]  J. Gerich,et al.  Renal glucose metabolism in normal physiological conditions and in diabetes. , 2017, Diabetes research and clinical practice.

[9]  F. Nitschke,et al.  Pathogenesis of Lafora Disease: Transition of Soluble Glycogen to Insoluble Polyglucosan , 2017, International journal of molecular sciences.

[10]  F. Ashcroft,et al.  Is Type 2 Diabetes a Glycogen Storage Disease of Pancreatic β Cells? , 2017, Cell metabolism.

[11]  R. Byard,et al.  Armanni–Ebstein Lesions in Terminal Hyperglycemia , 2017, Journal of forensic sciences.

[12]  N. Heyne,et al.  Impact of end-stage renal disease on glucose metabolism—a matched cohort analysis , 2017, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

[13]  V. Vallon,et al.  Targeting renal glucose reabsorption to treat hyperglycaemia: the pleiotropic effects of SGLT2 inhibition , 2017, Diabetologia.

[14]  A. Malik,et al.  Hyperglycemia induced damage to mitochondrial respiration in renal mesangial and tubular cells: Implications for diabetic nephropathy , 2016, Redox biology.

[15]  A. Hubert-Buron,et al.  Progressive development of renal cysts in glycogen storage disease type I. , 2016, Human molecular genetics.

[16]  Cheng Li,et al.  Molecular-size dependence of glycogen enzymatic degradation and its importance for diabetes , 2016 .

[17]  John M Lachin,et al.  Empagliflozin and Progression of Kidney Disease in Type 2 Diabetes. , 2016, The New England journal of medicine.

[18]  H. Yin,et al.  Crystal structure of glycogen debranching enzyme and insights into its catalysis and disease-causing mutations , 2016, Nature Communications.

[19]  W. Han,et al.  Pancreatic regulation of glucose homeostasis , 2016, Experimental & Molecular Medicine.

[20]  M. Adeva-Andany,et al.  Glycogen metabolism in humans☆☆☆ , 2016, BBA clinical.

[21]  F. Tinahones,et al.  Adipose tissue glycogen accumulation is associated with obesity-linked inflammation in humans , 2015, Molecular metabolism.

[22]  Roy Taylor,et al.  Diurnal variation in skeletal muscle and liver glycogen in humans with normal health and Type 2 diabetes. , 2015, Clinical science.

[23]  B. Schulz,et al.  Molecular structure of glycogen in diabetic liver , 2015, Glycoconjugate Journal.

[24]  Cheng Li,et al.  A rapid extraction method for glycogen from formalin-fixed liver. , 2015, Carbohydrate polymers.

[25]  M. Ramírez,et al.  Over-expression of muscle glycogen synthase in human diabetic nephropathy , 2015, Histochemistry and Cell Biology.

[26]  B. Kasinath,et al.  Activation of Glycogen Synthase Kinase 3β Ameliorates Diabetes-induced Kidney Injury* , 2014, The Journal of Biological Chemistry.

[27]  G. Pacini,et al.  Fasting and postprandial liver glycogen content in patients with type 1 diabetes mellitus after successful pancreas–kidney transplantation with systemic venous insulin delivery , 2014, Clinical endocrinology.

[28]  F. Warren,et al.  Changes in glycogen structure over feeding cycle sheds new light on blood-glucose control. , 2014, Biomacromolecules.

[29]  Lijun Li,et al.  Deletion of the insulin receptor in the proximal tubule promotes hyperglycemia. , 2013, Journal of the American Society of Nephrology : JASN.

[30]  H. Shahbazian,et al.  Diabetic kidney disease; review of the current knowledge , 2013, Journal of renal injury prevention.

[31]  A. Tamas,et al.  Effect of PACAP treatment on kidney morphology and cytokine expression in rat diabetic nephropathy , 2013, Peptides.

[32]  Yuan Zhang,et al.  Attenuation of Armanni–Ebstein lesions in a rat model of diabetes by a new anti-fibrotic, anti-inflammatory agent, FT011 , 2013, Diabetologia.

[33]  F. Mseeh,et al.  Improved glycemic control in mice lacking Sglt1 and Sglt2. , 2013, American journal of physiology. Endocrinology and metabolism.

[34]  R. Byard,et al.  Armanni–Ebstein Lesions: A Need for Clarification , 2013, Journal of forensic sciences.

[35]  D. Stapleton,et al.  The structure of cardiac glycogen in healthy mice. , 2012, International journal of biological macromolecules.

[36]  D. Stapleton,et al.  Molecular insights into glycogen α-particle formation. , 2012, Biomacromolecules.

[37]  J. Schnermann,et al.  Tubular control of renin synthesis and secretion , 2012, Pflügers Archiv - European Journal of Physiology.

[38]  S. Bulik,et al.  Quantifying the Contribution of the Liver to Glucose Homeostasis: A Detailed Kinetic Model of Human Hepatic Glucose Metabolism , 2012, PLoS Comput. Biol..

[39]  K. Suszták,et al.  Transcriptome Analysis of Human Diabetic Kidney Disease , 2011, Diabetes.

[40]  J. Gerich.  Role of the kidney in normal glucose homeostasis and in the hyperglycaemia of diabetes mellitus: therapeutic implications , 2010, Diabetic medicine : a journal of the British Diabetic Association.

[41]  Jace R. Drain,et al.  Comparative structural analyses of purified glycogen particles from rat liver, human skeletal muscle and commercial preparations. , 2009, International journal of biological macromolecules.

[42]  M. Duchen,et al.  Multiphoton imaging reveals differences in mitochondrial function between nephron segments. , 2009, Journal of the American Society of Nephrology : JASN.

[43]  J. Chou,et al.  Mutations in the glucose‐6‐phosphatase‐α (G6PC) gene that cause type Ia glycogen storage disease , 2008, Human mutation.

[44]  J. Wahren,et al.  Splanchnic regulation of glucose production. , 2007, Annual review of nutrition.

[45]  Chari D Smith,et al.  Glucose transporters in human renal proximal tubular cells isolated from the urine of patients with non-insulin-dependent diabetes. , 2005, Diabetes.

[46]  Z-W Yang,et al.  Glycogen accumulation in renal tubules, a key morphological change in the diabetic rat kidney , 2005, Acta Diabetologica.

[47]  D. Alessi,et al.  Role that phosphorylation of GSK3 plays in insulin and Wnt signalling defined by knockin analysis , 2005, The EMBO journal.

[48]  Michael Stumvoll,et al.  Type 2 diabetes: principles of pathogenesis and therapy , 2005, The Lancet.

[49]  P. Watt,et al.  Disruption of the striated muscle glycogen targeting subunit PPP1R3A of protein phosphatase 1 leads to increased weight gain, fat deposition, and development of insulin resistance. , 2003, Diabetes.

[50]  R. Robertson,et al.  Glucose toxicity in beta-cells: type 2 diabetes, good radicals gone bad, and the glutathione connection. , 2003, Diabetes.

[51]  M. Stumvoll,et al.  Altered homeostatic adaptation of first- and second-phase beta-cell secretion in the offspring of patients with type 2 diabetes: studies with a minimal model to assess beta-cell function. , 2003, Diabetes.

[52]  S. Welle,et al.  Role of human liver, kidney, and skeletal muscle in postprandial glucose homeostasis. , 2002, American journal of physiology. Endocrinology and metabolism.

[53]  E. Ferrannini,et al.  Influence of Long-Term Diabetes on Renal Glycogen Metabolism in the Rat , 2001, Nephron.

[54]  J. Gerich,et al.  Physiology of glucose homeostasis , 2000, Diabetes, obesity & metabolism.

[55]  M. Stumvoll,et al.  Role of glutamine in human carbohydrate metabolism in kidney and other tissues. , 1999, Kidney international.

[56]  M. Stumvoll,et al.  Abnormal renal and hepatic glucose metabolism in type 2 diabetes mellitus. , 1998, The Journal of clinical investigation.

[57]  M. Noda,et al.  Augmentation of Insulin Release by Glucose in the Absence of Extracellular Ca2+: New Insights Into Stimulus-Secretion Coupling , 1997, Diabetes.

[58]  G. Berry,et al.  Diabetes-like renal glomerular disease in Fanconi-Bickel syndrome , 1995, Pediatric Nephrology.

[59]  R. Rasch,et al.  Structure and Segmental Localization of Glycogen in the Diabetic Rat Kidney , 1993, Diabetes.

[60]  C. Bondy,et al.  Anatomical and developmental patterns of facilitative glucose transporter gene expression in the rat kidney. , 1993, The Journal of clinical investigation.

[61]  R. Rizza,et al.  Carbohydrate metabolism in non-insulin-dependent diabetes mellitus. , 1992, The New England journal of medicine.

[62]  I. Narama,et al.  Glycogen accumulation in the renal tubular cells of spontaneously occurring diabetic WBN/Kob rats. , 1990, Journal of comparative pathology.

[63]  W. Whelan,et al.  A self‐glucosylating protein is the primer for rabbit muscle glycogen biosynthesis , 1988, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[64]  R. Coleman,et al.  Renal disease in type I glycogen storage disease. , 1988, The New England journal of medicine.

[65]  R. Rasch.  Tubular lesions in streptozotocin-diabetic rats , 1984, Diabetologia.

[66]  S. Fineberg,et al.  Elevated Insulin/Glucagon Ratios and Decreased Cyclic AMP Levels Accompany the Glycogen and Triglyceride Storage Syndrome in the Hypothyroid Chick , 1980, Hormone and metabolic research = Hormon- und Stoffwechselforschung = Hormones et metabolisme.

[67]  H. Knull,et al.  The effect of streptozotocin-induced diabetes on glycogen metabolism in rat kidney and its relationship to the liver system. , 1979, Archives of biochemistry and biophysics.

[68]  D. Waugh,et al.  The pathology of Armanni-Ebstein diabetic nephropathy. , 1957, The American journal of pathology.

[69]  H. Bergman,et al.  THE RELATIONSHIP OF KIDNEY FUNCTION TO THE GLUCOSE UTILIZATION OF THE EXTRA ABDOMINAL TISSUES , 1938 .

[70]  H. Anders,et al.  CKD in diabetes: diabetic kidney disease versus nondiabetic kidney disease , 2018, Nature Reviews Nephrology.

[71]  G. Bakris,et al.  Title Diabetic kidney disease : a report from an ADA Consensus Conference , 2014 .

[72]  R. Atkins,et al.  Chronic kidney disease in the general population. , 2005, Advances in chronic kidney disease.

[73]  Yuan-Tsong Chen.  Type I glycogen storage disease: Kidney involvement, pathogenesis and its treatment , 2004, Pediatric Nephrology.

[74]  P. Garlick,et al.  Insulin regulation of renal glucose metabolism in humans. , 1999, The American journal of physiology.

[75]  K. Kurokawa,et al.  Substrate oxidation by defined single nephron segments of rat kidney. , 1980, The International journal of biochemistry.

[76]  M. West,et al.  Ultrastructural observations on renal glycogen in normal and pathologic human kidneys. , 1966, Laboratory investigation; a journal of technical methods and pathology.

[77]  B CHANCE,et al.  The respiratory chain and oxidative phosphorylation. , 1956, Advances in enzymology and related subjects of biochemistry.